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Abstract
Marek’s disease is a highly contagious disease of poultry characterized by rapid-on set of T-cell lymphomas, which
is caused by Marek’s disease virus (MDV), but its pathogenic mechanism is still not very clear. Recently, some new
progress were achieved in molecular character of MDV. Along with the genomic sequencing of MDV serotype 1,
some novel open reading frames (ORFs) were predicted, and ORF72.2 was one of them which have no homolo-
gues in other MDV serotypes or in other alphaherpesvirus. In the study, ORF72.2 was firstly identified as a protein-
coding gene by the method of reverse transcription polymerase chain reaction (RT-PCR), western blotting and
indirect immunofluorescence assay. This study paved the way to conduct further studies to determine whether
ORF72.2 plays a role in MDV replication and pathogenicity.
Findings
Marek’s disease (MD) is a highly contagious disease of
poultry characterized by mononuclear cellular infiltrates
in peripheral nerves and various other organs and tis-
sues including iris and skin. The disease has a world-
wide distribution and remains a major concern for the
poultry industry even though vaccines are used widely
today [1]. The causative agent of the disease is Gallid
herpesvirus 2, which is also called Marek’sd i s e a s ev i r u s
(MDV) serotype 1. This virus is an alphaherpesvirus of
the genus Mardivirus [2], which also includes the
antigen-related Meleagrid herpesvirus 1 (HVT), a strain
u s e dw i d e l ya sav a c c i n ea g a i n s tM Ds i n c et h el a t e
1960s [3,4], as well as Gallid herpesvirus 3 (MDV-2),
which includes apathogenic strains some of which are
used as live vaccines against MD [5].
The complete genomic sequence of the MDV-1 vac-
cine strain CVI988 was determined in 2007 which
consisting of 178311 bp with an overall gene organiza-
tion identical to that of the oncogenic strains such as
GA, RB1B, Md5, Md11, 584A. The genome of
CVI988-BAC contains over 478 ORFs encoding pro-
teins with more than 50 amino acid (aa) residues [6].
Among the ORFs, the putative functions of some
ORFs were predicted based on the comparison with
homologous genes of other alphaherpesvirus whose
functions had already been well known [7,8], however,
some ORFs are found to have no homologues in other
alphaherpesvirus. ORF72.2 in vaccine strain CVI988
was one of those ORFs and consists of 621 nucleo-
tides, encoding 206 aa residues. In this study, the
ORF72.2 protein was firstly indentified, expressed and
localized in cell by western blotting and immunofluor-
escence assay, which laid the foundation for the study
of pathogenic mechanism of MDV.
The MDV CVI988 strain used in this study was grown
in chicken embryo fibroblast (CEF) cells. Cell cultures
were maintained in modified Eagle’sm e d i u m( M E M )
supplemented with 10% fetal bovine serum (FBS), 0.22%
NaHCO3, 100 IU/ml penicillin and streptomycin [9].
The RNA was extracted using RNAprep pure Cell Kit
(TIANGEN, Beijing, China) from normal CEFs and
MDV-infected CEFs at 24 h, 48 h, 72 h, 96 h post-
infection. Then a pair of primers were designed based
on the bioinformatics analysis (Primer Premier 5.0 soft-
ware) of the ORF72.2 gene and used to amplify a 590
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ORF72.2 gene, and the amplification was performed
with reverse transcription polymerase chain reaction
(RT-PCR) (Figure 1). The sequences of the primers used
for this purpose were R1: 5’-CCGGAATTCCCTGA
TACTGCTAAGAGATCAC-3’ with EcoRI site (under-
lined) and R2: 5’-CCCAAGCTTCGTATACAGCCGAA
CATAAT-3’ with Hind III site (underlined). The result
showed that the ORF72.2 gene was successfully ampli-
fied from MDV-infected CEFs by RT-PCR at all time
points tested, which suggested that the ORF72.2 gene
was transcribed persistently in middle and late time of
viral infection.
The amplified product was cloned into pET32 (+)
plasmid to get a recombinant plasmid named pET32-
ORF72.2. Escherichia coli BL21 (DE3) were transformed
with the recombinant plasmid, and protein expression
was induced with 1 mM IPTG at 37°C for 4 h. The bac-
terial proteins were analyzed by 12% SDS-PAGE under
denaturing conditions. Protein bands were visualized
after staining with 0.1% Coomassie blue R250, and the
protein concentration was determined using program
BandScan 5.0 [10]. The recombinant ORF72.2 protein
with molecular weight of about 41 KDa by SDS-PAGE
analysis was successfully expressed in the transformed
cells (Figure 2).
The expressed recombinant ORF72.2 protein was
trapped in inclusion bodies. The cells were harvested by
centrifugation and resuspended in Phosphate-Buffered
Saline (PBS) (pH 8.0) containing lysozyme (0.1 mg/mL)
by 1/10 (v/v), after ice bathing for 30 min, the suspension
were sonicated and centrifuged at 12000 g for 10 min.
The pellets were homogenated and washed with washing
buffer [50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.2%
Triton X-100, 2 M urea] for three times at 10 min/times
and centrifugated at 12000 g for 10 min. The pellets were
dissolved by denaturation buffer [50 mM Tris-HCl (pH
8.0), 2 mM 2-mercaptoethanol, 8 M urea] and superna-
tant were collected after centrifugation. The supernatant
was treated with renaturation buffer [50 mM Tris-HCl
(pH 8.0), 0.1 mM oxidized glutathione, 1 mM reduced
glutathione, 0.5 M urea] for overnight at 4°C and filtrated
through 0.45 uM filtration membrane. Then the solution
was purified on a column packed with Ni-NTA His Bind
superflow according to the manufacture’s instruction
(Merck, Darmstadt, Germany). Bound protein fractions
were pooled, dialyzed and concentrated, and the protein
expression yield was analyzed by Bradford assay [11]. For
the purified fusion protein, a single objective band was
detected by SDS-PAGE (Figure 2).
For production of chicken antiserum against MDV,
1-day-old specific pathogen-free (SPF) chicken were
injected intraperitoneally (i.p) with 0.2 ml of MDV
CVI988 (Intervet) containing 4000 plague forming unit
(PFU), and booster injection was done at days 10 using
t h es a m em e t h o d[ 1 2 ] .T w ow eeks after immunization,
the blood was harvested from jugular vein and the anti-
serum was isolated. The serum of non-immunized
chicken was also isolated as control.
For production of rabbit antiserum against recombi-
nant ORF72.2 protein, New Zealand white rabbits were
first immunized intradermally with 1 mg purified recom-
binant protein mixed with an equal volume of complete
Freund adjuvant (Sigma, Shanghai, China) and with puri-
fied recombinant protein mixed with an equal volume of
incomplete Freund adjuvant on days 14 and 28 later as
booster injection, respectively. The serum was collected
at 10 days after the final booster injection. The antiserum
was purified using ammonium sulfate precipitation and
High-Q anion-exchange chromatography [13].
To testify indirectly whether the ORF72.2 protein can
be expressed in chickens after MDV CVI988 infection,
the chicken antiserum against MDV produced above
was used to make a western-blot. Firstly, purified
recombinant proteins were separated by SDS-PAGE,
and then the proteins were transferred to Polybinylidene
Difluoride (PVDF) membrane with 0.25 uM pore size
(Millipore Corp., USA) at 15 V for 1.5 h. Then the
Figure 1 Amplification results of ORF72.2 gene by RT-PCR.M :
DNA Marker DL2000; Lane 1: RT-PCR result of ORF72.2 gene from
MDV-infected CEFs; Lane 3: RT-PCR result of ORF72.2 gene from
normal CEFs.
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mM Tris-HCl (pH8.0), 150 mM NaCl, 0.05% Tween 20,
5% skinned dry milk] at 37°C and washed with Tris-Buf-
fered Saline with Tween 20 (TBST) buffer [20 mM Tris-
HCl (pH8.0), 150 mM NaCl, 0.05% Tween20] for three
times. Then the membrane was incubated with chicken
a n t i s e r u md i l u t e d1 : 5 0i n0 . 1 %B o v i n eS e r u mA l b u m i n
(BSA)/PBS for 60 min at 37°C and washed with TBST,
and then incubated with horseradish peroxidase (HRP)-
labeled rabbit-anti-chicken IgG (Zhongshan Golden-
bridge Biotechology co., Ltd, Beijing, China) for 60 min
at 37°C. Target proteins were visualized using 3, 3’-Dia-
minobezidine (DAB) (TIANGEN, Beijing, China). The
result of western blotting showed the fusion protein can
react positively with chicken antiserum against MDV
(Figure 3), which proved that the ORF72.2 protein can
be expressed in chickens after MDV infection and an
immune response can be induced by natural ORF72.2
protein, but band line of western blotting was light,
implying the expression level or immunogenicity of
natural ORF72.2 protein in chicken after MDVs infec-
tion is weak.
To further confirm the existence of ORF72.2 protein
in MDV-infected CEFs, indirect immunofluorescence
studies were performed with the rabbit antiserum
against recombinant ORF72.2 protein produced above.
CEFs were mock-infected or infected with MDV and
were collected at 72 h post-infection when cytopatho-
genic effect (CPE) had just appeared. Cells on coverslips
were fixed with 4% cold paraformaldehyde for overnight
at 4°C and treated with 3% BSA to block the nonspecific
staining, and then permeabilized with 0.2% (v/v)
TrionX-100 in PBS for 20 min at room temperature.
The samples were incubated with rabbit antiserum
against recombinant ORF72.2 protein diluted in 1:100
for overnight at 4°C and washed with TBST for three
times, and then incubated with fluorescein isothiocya-
nate (FITC)-conjugated sheep-anti-rabbit IgG (Zhong-
shan Goldenbridge Biotechology co., Ltd, Beijing, China)
f o r1ha t3 7 ° C[ 1 4 , 1 5 ] .T h er e s u l ts h o w e dt h a ts p e c i f i c
Figure 2 Results of expression and purification of recombinant ORF72.2 protein.M :p r o t e i nm a r k e r ;L a n e1 :t h et o t a lc e l lp r o t e i n so f
uninduced BL21 containing recombinant plasmid; Lane 2: the total cell proteins of induced BL21 containing recombinant plasmid; Lane 3: the
supernatant of cell lysate of induced BL21 containing recombinant plasmid; Lane 4: purified fusion protein.
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brane region of infected cells at 72 h post-infection
(Figure 4).
In this study, ORF72.2 gene was identified from MDV
CVI988 in the level of transcription and expression.
Firstly, mRNA was extracted from CEFs infected by
CVI988 using RT-PCR, whi c hp r o v e dt h a tO R F 7 2 . 2
gene is successfully transcribed in infected cells. Sec-
ondly, the highly antigenic region of ORF72.2 gene was
successfully cloned and expressed in an E. coli pET32
(+) expression system. Thirdly, the existence of antibo-
dies against natural ORF72.2 protein in chickens after
MDV infection was verified by western blotting using
recombinant ORF72.2 protein as the antigen. Mean-
while, the existence of ORF72.2 protein in MDV-
infected CEFs was further verified by immunofluores-
cence assay using rabbit antiserum against recombinant
protein. Generally, natural ORF72.2 protein was found
in MDV infected cells and natural antibodies against
ORF72.2 protein can be detected in chicken after MDV
infection, all this proved that ORF72.2 gene is really a
novel protein-coding gene of MDV.
In addition, bioinformatics analysis of the complete
genomic sequence of MDV revealed that ORF72.2 gene
existed both in mild virulent MDVs (such as CU-2) and
high virulent MDVs (such as GA, RB1B, MD5, MD11,
584A), but it was only found in MDV serotype 1 and its
homologous gene was not identified in MDV serotype 2
and 3 or in other alphaherpesvirus. Deduced amino acid
sequence of ORF72.2 was searched for the existence of
protein motifs in the PROSITE pattern database and the
function of this protein was searched too, but no avail-
able database and protein motifs could be found.
Figure 3 Demonstration of antibodies against ORF72.2 protein
in serum of MDV-infected chickens by Western blotting.M :
protein marker; Lane 1: purified fusion protein; Lane 2: Western-blot
result of purified recombinant protein with chicken antiserum
against MDV; Lane3: Western-blot result of purified recombinant
protein with serum from normal chickens.
Figure 4 Detection of ORF72.2 protein by immunofluorescence assay in non-infected CEFs (A) and MDV-infected CEFs (B).C E F sw e r e
incubated with rabbit antiserum against recombinant ORF72.2 protein, and subsequently stained with fluorescein isothiocyanate (FITC)-
conjugated sheep-anti-rabbit IgG. Nuclear were counterstained with DAPI (blue).
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Page 4 of 5In conclusion, a novel protein encoded by ORF72.2
gene was identified and verified by method of western
blotting and indirect immunofluorescence assay (IFA),
however, it was not really clear whether this protein is
important to the replication and pathogenicity of MDV,
further study should be undertaken in the following
study.
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